Clinical Trials for Transgender Drugs in Children Underway in the UK

In the UK, children aged 10 and older are set to participate in clinical trials involving transgender medications, despite the government’s prohibition on the public use of puberty blockers.

Last year, a prominent study led by pediatrician Dr. Hilary Cass suggested that the practice of transgender medical treatments was “built on shaky foundations.” The findings pointed to significant safety concerns, prompting the left-leaning Labour government to ban administering puberty blockers to minors.

Interestingly, Cass’s review also opens the possibility for future medical trials. This week, regulatory approval was granted for a study involving 250 children aged 10 to 15 who identify as transgender, as reported by The Times of London.

According to the newspaper, over half of the participants will receive drugs for up to two years to inhibit natural development—this includes suppressing menstrual cycles, breast growth, and facial hair. Researchers will monitor their brain development and other health markers, comparing them to children who do not undergo the treatment as they approach adulthood.

The research team from King’s College contended that the study is essential for providing transgender-identified children with “the information they need to make informed choices about their care.”

Professor Emily Simonoff, who is leading the study, emphasized that parental consent will be necessary throughout the trial. However, she did acknowledge the potential for long-term negative consequences, including impacts on fertility, mental health, and skeletal development.

Despite this, Professor Simonoff mentioned that the trial aims to determine if better alignment of physical traits with long-term identity could help alleviate anxiety and depression.

The announcement provoked a swift backlash from both political and medical communities. Dr. Alice Hodkinson, representing the Biology in Medicine doctors’ campaign group, remarked, “There is already clear evidence of harm,” urging NHS England to halt the trial and prioritize a thorough assessment of the 2,000 children currently receiving puberty blockers.

Former Prime Minister Liz Truss commented, “Just when you think transgender ideology has been defeated, it rebels again. Doing this to children is evil. It should be a crime.”

In a letter responding to Health Secretary Wes Streeting, independent MP Rupert Lowe expressed deep concern and disgust at the decision to approve a new clinical trial for puberty blockers in children. He described the study as “a deeply unethical experiment that must be stopped immediately,” arguing that exposing children to such medical interventions is neither safe nor ethically justified. He remarked, “No child is born in the wrong body. To suggest otherwise is a grossly irresponsible abuse of power.”